FORMEL SKIN, an innovative HealthTech start-up revolutionizing the dermatology landscape, proudly announces a significant funding milestone of 33,900,000 raised to date. This success underscores investor confidence in the company’s mission to deliver individualized, high-quality medical treatments online by fusing advanced technology with traditional healthcare expertise. Through an intuitive platform, patients can register online, complete a comprehensive questionnaire, and upload photos of their skin concerns, enabling FORMEL SKIN to assign a personal doctor who determines customized treatment plans. Tailored medications, prepared through partnered pharmacies and conveniently shipped monthly, address patient needs with precision and care. With this new capital infusion, FORMEL SKIN is poised to accelerate its growth and extend its reach across Europe, overcoming current challenges faced by dermatologists and patients alike. The funding will be strategically used to scale the digital platform, enhance data-driven decision-making processes, and drive further innovation in personalized dermatological care. Additionally, the capital will support the expansion of the expert medical team and the refinement of the online consultation experience, ensuring patients receive timely and effective treatment adjustments based on ongoing feedback and results. Having already attracted backing from Europe’s leading early-stage venture capital firms, Cherry Ventures and Heartcore Capital, the current funding round not only fuels operational growth but also reinforces the trust that top investors have in the company's model. As FORMEL SKIN embarks on its next phase of expansion, its commitment to transforming the skin care journey for millions of patients remains steadfast, promising a future filled with enhanced accessibility, responsiveness, and quality in dermatological treatments.
FORMEL SKIN Secures €33.9M Series A Funding to Transform Digital Dermatology
Get the full FORMEL SKIN company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Garner Health
We believe in transparency, data-driven decision-making, and seamless customer experiences. That’s why we’re building solutions to help employees discover high-quality doctors. Our team includes healthcare operators, clinicians, engineers, and benefits experts, allowing us to develop solutions with a multidisciplinary approach.
$45.0M Series b
today
Signos
Signos is the first FDA-cleared metabolic health platform that helps employees understand and improve their metabolism in real-time, providing employers with the data to make informed benefits decisions. Powered by Dexcom’s Stelo CGM and AI-driven guidance, Signos turns glucose data into personalized, actionable recommendations that support sustainable weight management and better metabolic health. For employers, this means healthier populations, reduced reliance on GLP-1 medications, and more predictable benefit costs through data-driven, predictive health.
$20.0M Series b
today
Third Wave Coffee
Third Wave Coffee is a coffee and food QSR brand founded by Ayush Bathwal, Anirudh Sharma and Sushant Goel in 2015. With a commitment to quality and innovation, the homegrown coffee QSR chain has rapidly expanded to over 140 stores nationwide, earning a reputation as one of the fastest-growing coffee brands in the country. Third Wave Coffee is dedicated to providing a high-quality coffee-first experience to its customers across the country with a specific focus on high-quality beans, convenient locations and a technology-enabled consumer experience. Celebrated as a trailblazer in the industry, the brand was recognised as one of the ET Now Best Brands of 2024. For more information, visit Third Wave Coffee at https://www.thirdwavecoffeeroasters.com.
$80.0M Unknown
today
Enttor
The only outbound software startups need
$410.0K Seed
today
Return Helper
Return Helper provides a unified intelligence platform for cross-border e-commerce, bridging the gap between global sales and local disposal. With deep integration across 20+ strategic hubs in Europe, the Americas, and Asia, we resolve the complexity of international returns for sellers on Amazon, Shopify, and eBay. Our Infrastructure: End-to-End Fulfillment: Precision management for Fashion, Electronics, Furniture, and Baby products. Asset Recovery: We don’t just process returns; we revive them. Through local resale and strategic recycling, we achieve a 70% recovery rate, ensuring inventory stays in the commerce cycle rather than the landfill. Strategic Compliance: Aligning operational excellence with global ESG mandates to future-proof your post-purchase experience.
$4.0M Series a
today
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 | Return Helper Singapore | Series a | $4.0M | today |
| 2 |  iNaira Healthcare Technologies United States | Series a | $920.0K | today |
| 3 |  Picogrid United States | Series a | $45.0M | today |
| 4 |  Waypoint Bio United States | Series a | $20.0M | 1d ago |
| 5 |  Default United States | Series a | $20.0M | 1d ago |